Cargando…

Endothelial Cell Activation and Thrombin Generation Assessment for the Risk of Severe Early Onset Preeclampsia. the ROADMAP-EOP Study

BACKGROUND: The ROADMAP-EOP study aimed to identify clinically relevant biomarkers of hypercoagulability for the identification of pregnant women at risk of early onset preeclampsia worsening. METHODS: The ROADMAP-EOP observational single center retrospective case–control study was conducted in Gree...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Dreden, Patrick, Lefkou, Eleftheria, Ka, Aboubakar, Sfakianoudis, Konstantinos, Rousseau, Aurélie, Grusse, Matthieu, Elalamy, Ismail, Gerotziafas, Grigoris T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677286/ http://dx.doi.org/10.1177/10760296221138296

Ejemplares similares

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study
por: Gerotziafas, Grigoris T., et al.
Publicado: (2017)

Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study
por: Gerotziafas, Grigoris T., et al.
Publicado: (2020)

The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Sex Hormone Levels, Biomarkers of Hypercoagulability and Endothelial Cell Activation Are Determinants of Severity of COVID-19 in Women and Men. the Roadmap-COVID-19 Prospective Study
por: Van Dreden, Patrick, et al.
Publicado: (2022)

Persisting Endothelial Cell Activation and Hypercoagulability after Recovering from COVID-19: The Roadmap-Post COVID-19 Study
por: Van Dreden, Patrick, et al.
Publicado: (2022)

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study
por: Van Dreden, Patrick, et al.
Publicado: (2020)

Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots
por: Salta, Stella, et al.
Publicado: (2018)

Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum?
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study
por: Fotiou, Despina, et al.
Publicado: (2018)

Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay
por: Gerotziafas, Grigoris T, et al.
Publicado: (2005)

Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19
por: Gerotziafas, Grigoris, et al.
Publicado: (2020)

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study
por: Souliotis, Kyriakos, et al.
Publicado: (2022)

Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability
por: Chaari, Mourad, et al.
Publicado: (2014)

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients
por: Gerotziafas, Grigoris T, et al.
Publicado: (2014)

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
por: Mahé, Isabelle, et al.
Publicado: (2019)

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
por: Mahé, Isabelle, et al.
Publicado: (2019)

Thrombotic and Hemorrhagic Issues Associated with Myeloproliferative Neoplasms
por: Papageorgiou, Loula, et al.
Publicado: (2022)

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process
por: Papageorgiou, Loula, et al.
Publicado: (2019)

SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Elalamy, Ismail, et al.
Publicado: (2021)

C1-inhibitor influence on platelet activation by thrombin receptors agonists
por: Tarandovskiy, Ivan D., et al.
Publicado: (2022)

Fibrinolytic Changes in Women with Preeclampsia
por: Godtfredsen, Anne Cathrine, et al.
Publicado: (2022)

Increased In Vivo Thrombin Generation in Patients with Localized Non-Small Cell Lung Cancer Unfit for Surgery
por: Hojbjerg, Johanne Andersen, et al.
Publicado: (2023)

Impact of Stereotactic Body Radiotherapy on Thrombin Generation and Platelet Aggregation in Patients with Non-Small Cell Lung Cancer
por: Bentsen, Kristian Kirkelund, et al.
Publicado: (2023)

Thrombin Generation Decrease After LMWH Administration in an Antithrombin-Deficient Pregnant Woman With a Homozygous HBS II Mutation
por: Malikova, Ivana, et al.
Publicado: (2023)

Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies
por: Papageorgiou, Chrysoula, et al.
Publicado: (2018)

Assessment of Rotational Thromboelastometry and Thrombin Generation Assay to Identify Risk of High Blood Loss and Re-Operation After Cardiac Surgery
por: Jeong, Dajeong, et al.
Publicado: (2022)

Relationship Between Polymorphism of Thrombin-Activatable Fibrinolysis Inhibitor Gene +1040C/T and a Cohort of Chinese Women With Recurrent Spontaneous Abortion
por: Fang, Ping, et al.
Publicado: (2021)

Absolute IOP/EOP Estimation Models without Initial Information of Various Smart City Sensors
por: Kim, Namhoon, et al.
Publicado: (2023)

Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis
por: Li, Juanzhen, et al.
Publicado: (2022)

Association Between Thrombin–Antithrombin Complex and Acute Kidney Injury After Pediatric Cardiopulmonary Bypass Surgery: A Single-Center Retrospective Observational Study
por: Minami, Sakura, et al.
Publicado: (2023)

Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA
por: Yang, Yong, et al.
Publicado: (2022)

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study
por: Gerotziafas, Grigoris T., et al.
Publicado: (2017)

Immature Platelet Fraction and Thrombin Generation: Preeclampsia Biomarkers
por: Moraes, Daniela, et al.
Publicado: (2022)

Coagulation Factors and Natural Anticoagulants as Surrogate Markers of Preeclampsia and Its Subtypes: A Case–Control Study in a Ghanaian Population
por: Mintaah, Selina, et al.
Publicado: (2023)

Comparison of Early and Late Onset Psoriasis (EOP and LOP) Regarding Systemic Inflammatory Comorbidities: LOP is a More Rapid Subtype of Psoriasis
por: Huseynova Terzi, Leyla, et al.
Publicado: (2022)

Exploring depression in adolescents: How depression changes in early onset psychosis (EOP), clinical high risk (UHR) and clinical control (CC) patients
por: Monducci, E., et al.
Publicado: (2021)

Position Paper on the Management of Pregnancy-Associated Superficial Venous Thrombosis. Balkan Working Group for Prevention and Treatment of Venous Thromboembolism
por: Antic, Darko, et al.
Publicado: (2022)

HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease
por: Festoff, Barry W., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fc7e7n9boc7j6jskasmartsb2u